Literature DB >> 28508178

Survey about the use of clarithromycin in an ENT outpatient department of a tertiary hospital.

Jingchao Yan1, Jianwen Shen2, Ying Li2, Fengmin Tang2, Nianzu Chen2.   

Abstract

We undertook this survey about the use of clarithromycin in the Ear, Nose, and Throat (ENT) Outpatient Department of Fudan University Hospital to understand its utilization patterns and rational use. A survey of prescriptions given to outpatients was carried out, and detailed information of the patients, including age, sex, diagnosis, combined medication, and other information, was recorded in Excel spreadsheets. The rationale for each prescription was evaluated retrospectively. Based on our analysis, 82.5% of the clarithromycin prescriptions were for the treatment of rhinosinusitis. It was found that the parameters for the diagnosis of this condition were surprisingly broad and should have been more specific. In addition, the clarithromycin dosage regimen varied in clinical practice. For chronic rhinosinusitis, the duration of treatment was between 8 and 16 days, which was not sufficient. Moreover, clarithromycin was prescribed along with considerable numbers of pharmacotherapeutic anti-allergic drugs. Our survey indicated that improvements in the quality of clarithromycin prescriptions in otolaryngology outpatients should be made. Furthermore, the importance of medical education to patients should be emphasized. In addition, the interaction between clarithromycin and other anti-allergic drugs requires further investigation.

Entities:  

Keywords:  Antibiotics; Clarithromycin; Drug interactions; Drug utilization; Otolaryngology outpatients; Prescriptions

Mesh:

Substances:

Year:  2017        PMID: 28508178     DOI: 10.1007/s00405-017-4607-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  11 in total

1.  EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists.

Authors:  Wytske Fokkens; Valerie Lund; Joaquim Mullol
Journal:  Rhinology       Date:  2007-06       Impact factor: 3.681

2.  High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis.

Authors:  Y Fan; R Xu; H Hong; Q Luo; W Xia; M Ding; J Shi; M Lv; H Li
Journal:  J Laryngol Otol       Date:  2014-02-20       Impact factor: 1.469

3.  Biofilms in chronic rhinosinusitis with polyps: is eradication possible?

Authors:  Hakan Korkmaz; Bülent Ocal; Emel Cadallı Tatar; Ilkan Tatar; Ali Ozdek; Güleser Saylam; Hakan Hamdi Celik
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-02-08       Impact factor: 2.503

4.  Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration.

Authors:  R A Carr; A Edmonds; H Shi; C S Locke; L E Gustavson; J C Craft; S I Harris; R Palmer
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 5.  Effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review.

Authors:  Zu-Liang Shi; Hui Peng; Xian-Wei Hu; Jie-Gui Hu
Journal:  Pulm Pharmacol Ther       Date:  2013-09-25       Impact factor: 3.410

6.  Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Authors:  K M Hare; K Grimwood; A B Chang; M D Chatfield; P C Valery; A J Leach; H C Smith-Vaughan; P S Morris; C A Byrnes; P J Torzillo; A C Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-09-12       Impact factor: 3.267

7.  Drug safety of macrolide and quinolone antibiotics in a tertiary care hospital: administration of interacting co-medication and QT prolongation.

Authors:  David Niedrig; Sarah Maechler; Liesa Hoppe; Natascia Corti; Helen Kovari; Stefan Russmann
Journal:  Eur J Clin Pharmacol       Date:  2016-03-29       Impact factor: 2.953

Review 8.  Otitis media: diagnosis and treatment.

Authors:  Kathryn M Harmes; R Alexander Blackwood; Heather L Burrows; James M Cooke; R Van Harrison; Peter P Passamani
Journal:  Am Fam Physician       Date:  2013-10-01       Impact factor: 3.292

Review 9.  Treating common problems of the nose and throat in pregnancy: what is safe?

Authors:  Petros V Vlastarakos; Leonidas Manolopoulos; Eleftherios Ferekidis; Aris Antsaklis; Thomas P Nikolopoulos
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-12       Impact factor: 2.503

10.  Changes in Chinese policies to promote the rational use of antibiotics.

Authors:  Yonghong Xiao; Jing Zhang; Beiwen Zheng; Lina Zhao; Sujuan Li; Lanjuan Li
Journal:  PLoS Med       Date:  2013-11-19       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.